These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 21948617)

  • 1. [Raltegravir in a special case: patient with HIV and Burkitt's lymphoma].
    Bieniek B
    Dtsch Med Wochenschr; 2011 Oct; 136(41):2091-3. PubMed ID: 21948617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Raltegravir-based HAART regimen in a patient with large B-cell lymphoma.
    Fulco PP; Hynicka L; Rackley D
    Ann Pharmacother; 2010 Feb; 44(2):377-82. PubMed ID: 20040700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Successful treatment with hyper-CVAD and highly active anti-retroviral therapy (HAART) for AIDS-related Burkitt lymphoma].
    Suzuki K; Nakazato T; Sanada Y; Mihara A; Tachikawa N; Kurai H; Yoshimura Y; Hayashi H; Yoshida S; Kakimoto T
    Rinsho Ketsueki; 2010 Mar; 51(3):207-12. PubMed ID: 20379116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful administration of aggressive chemotherapy concomitant to tuberculostatic and highly active antiretroviral therapy in a patient with AIDS-related Burkitt's lymphoma.
    Lehmann C; Wyen C; Hoffmann C; Fätkenheuer G
    HIV Med; 2005 Jan; 6(1):51-3. PubMed ID: 15670254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Burkitt's lymphoma shortly after an acute HIV infection, treated with highly active retroviral treatment.
    Colebunders R; Dohmen S; Van de Velde A; Pelgrom J; Hermans P
    Acta Clin Belg; 2001; 56(5):321-2. PubMed ID: 11770227
    [No Abstract]   [Full Text] [Related]  

  • 6. AIDS-related Burkitt's lymphoma versus diffuse large-cell lymphoma in the pre-highly active antiretroviral therapy (HAART) and HAART eras: significant differences in survival with standard chemotherapy.
    Lim ST; Karim R; Nathwani BN; Tulpule A; Espina B; Levine AM
    J Clin Oncol; 2005 Jul; 23(19):4430-8. PubMed ID: 15883411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excellent immunological recovery following CODOX-M/IVAC, an effective intensive chemotherapy for HIV-associated Burkitt's lymphoma.
    Montoto S; Wilson J; Shaw K; Heath M; Wilson A; McNamara C; Orkin C; Nelson M; Johnson M; Bower M; Cwynarski K
    AIDS; 2010 Mar; 24(6):851-6. PubMed ID: 20124971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High dose therapy and autologous stem cell transplantation for human immunodeficiency virus-associated non-Hodgkin lymphoma in the era of highly active antiretroviral therapy.
    Molina A; Krishnan AY; Nademanee A; Zabner R; Sniecinski I; Zaia J; Forman SJ
    Cancer; 2000 Aug; 89(3):680-9. PubMed ID: 10931469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment and prognosis of AIDS-related lymphoma in the era of highly active antiretroviral therapy: findings from the Swiss HIV Cohort Study.
    Simcock M; Blasko M; Karrer U; Bertisch B; Pless M; Blumer L; Vora S; Robinson JO; Bernasconi E; Terziroli B; Moirandat-Rytz S; Furrer H; Hirschel B; Vernazza P; Sendi P; Rickenbach M; Bucher HC; Battegay M; Koller MT;
    Antivir Ther; 2007; 12(6):931-9. PubMed ID: 17926647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Durable survival after chemotherapy in a HIV patient with Burkitt's lymphoma presenting with massive upper gastrointestinal bleeding.
    Law MF; Chan HN; Pang CY; Lai HK; Ha CY; Ng C; Ho R; Wong CK; Yeung YM; Yip SF
    Int J STD AIDS; 2016 Jul; 27(8):690-6. PubMed ID: 26185043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose chemotherapy and immunotherapy in adult Burkitt lymphoma: comparison of results in human immunodeficiency virus-infected and noninfected patients.
    Oriol A; Ribera JM; Bergua J; Giménez Mesa E; Grande C; Esteve J; Brunet S; Moreno MJ; Escoda L; Hernandez-Rivas JM; Hoelzer D
    Cancer; 2008 Jul; 113(1):117-25. PubMed ID: 18457327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensive sequential chemotherapy with hematopoietic growth factor support for non-Hodgkin lymphoma in patients infected with the human immunodeficiency virus.
    Costello RT; Zerazhi H; Charbonnier A; de Colella JM; Alzieu C; Poizot-Martin I; Cohen R; Bardou VJ; Xerri L; Olive D; Nezri M; Lepeu G; Gastaut JA
    Cancer; 2004 Feb; 100(4):667-76. PubMed ID: 14770420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human immunodeficiency virus-associated Burkitt's lymphoma in oral cavity of Japanese patient.
    Goto M; Onizawa K; Yanagawa T; Yamagata K; Shinozuka K; Nishikii H; Koganemaru H; Chiba S; Bukawa H
    J Oral Maxillofac Surg; 2012 Aug; 70(8):1885-90. PubMed ID: 22079069
    [No Abstract]   [Full Text] [Related]  

  • 14. High-dose therapy plus autologous hematopoietic stem cell transplantation for human immunodeficiency virus (HIV)-related lymphoma: results and impact on HIV disease.
    Gabarre J; Marcelin AG; Azar N; Choquet S; Lévy V; Lévy Y; Tubiana R; Charlotte F; Norol F; Calvez V; Spina M; Vernant JP; Autran B; Leblond V
    Haematologica; 2004 Sep; 89(9):1100-8. PubMed ID: 15377471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant lymphoma in the HIV-positive patient.
    Meister A; Hentrich M; Wyen C; Hübel K
    Eur J Haematol; 2018 Jul; 101(1):119-126. PubMed ID: 29663523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensive chemotherapy with cyclophosphamide, doxorubicin, high-dose methotrexate/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M/IVAC) for human immunodeficiency virus-associated Burkitt lymphoma.
    Wang ES; Straus DJ; Teruya-Feldstein J; Qin J; Portlock C; Moskowitz C; Goy A; Hedrick E; Zelenetz AD; Noy A
    Cancer; 2003 Sep; 98(6):1196-205. PubMed ID: 12973843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-related and Epstein-Barr virus-associated anal Burkitt's lymphoma: report of a case.
    Freudenberg S; Palma P; Grobholz R; Ngendahayo L; Post S
    Dis Colon Rectum; 2005 Aug; 48(8):1656-9. PubMed ID: 16034658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of raltegravir in the treatment of HIV-2 infections: evidence from a case series.
    Peterson K; Ruelle J; Vekemans M; Siegal FP; Deayton JR; Colebunders R
    Antivir Ther; 2012; 17(6):1097-100. PubMed ID: 22892365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose therapy and autologous peripheral-blood stem-cell transplantation as salvage treatment for HIV-associated lymphoma in patients receiving highly active antiretroviral therapy.
    Re A; Cattaneo C; Michieli M; Casari S; Spina M; Rupolo M; Allione B; Nosari A; Schiantarelli C; Vigano M; Izzi I; Ferremi P; Lanfranchi A; Mazzuccato M; Carosi G; Tirelli U; Rossi G
    J Clin Oncol; 2003 Dec; 21(23):4423-7. PubMed ID: 14581441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination antiretroviral therapy as treatment for human immunodeficiency virus-associated mucosa-associated lymphoid tissue type lymphoma of the nasopharynx.
    Varma R; Carroll SL; Jacobson IV; Milross CG; Post JJ
    Intern Med J; 2011 May; 41(5):437-8. PubMed ID: 21605299
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.